RABI-767 FOR SEVERE ACUTE PANCREATITIS

RABI-767 is a small molecule lipase inhibitor that has shown profound efficacy in the treatment of acute pancreatitis in multiple clinically relevant mouse models. Our development program will build on the groundbreaking discovery in these models that lipase inhibition is able to prevent the serious and debilitating systemic toxicity and organ failure associated with severe acute pancreatitis.